Drugs / Hydroxypropyl Guar Galactomannan
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00840268 | Feb → Jul 2009 | dry eye syndrome | Alcon Research | Completed | No outcome recorded |
| Phase 2 | NCT00760045 | Aug → Oct 2008 | dry eye syndrome | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hydroxypropyl Guar Galactomannan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00760045 ↗ |
| Known as | HPGG | “Hydroxypropyl Guar Galactomannan (HPGG) 0.25% ophthalmic gel” NCT00840268 ↗ |